Respiratory Metagenomics Expansion Programme to Oxford Nanopore Technologies PLC

Description

The delivery of a National NHS Respiratory Metagenomics Expansion Programme to a network of 30 NHS sites across the UK. Lot 1: Direct Award. The Trust has been granted funding from the Department of Science, Innovation and Technology (DSIT), with oversight delegated to the Office of Life Sciences (OLS), for the delivery of the NHS Respiratory Metagenomics Expansion Programme, in which GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with ONT developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance. <br/>The contract period is for Three Years and will expire on 20th November 2028. The approximate lifetime value of the contract is <br/>The contract will be grant funded from the DSIT award to GSTT for the NHS Respiratory Metagenomics Expansion Programme.